Glycos Biotechnologies Featured in Accenture Report as Offering Evolutionary Technology
Microbial Conversion Technology Uniquely Produces High-Value Chemicals and Fuels from Disadvantaged Low Cost Feedstocks
HOUSTON, TX – December 15, 2009 – Glycos Biotechnologies, Inc. (GlycosBio), an emerging biochemical company pioneering metabolic engineering and microbiology innovations that produce green chemicals, today announced the company’s inclusion in Accenture’s recent report, “Betting on Science, Disruptive Technologies in Transport Fuels”.
Issued on November 10, 2009, the study identified 12 innovations most likely to positively transform the supply and demand landscape of sustainable transport fuels and biochemicals within the next five years. GlycosBio was among 25 companies profiled that aim to bring these unique innovations to market.
“To help meet the world’s growing demand for sustainable biochemicals and biofuels, it’s essential for the industry to understand that emerging biological techniques can be economically complementary to traditional chemical and fuel processes,” said Rich Cilento, Executive Chairman, Glycos Biotechnologies. “Recent advancements in microbiology can enable chemical and fuel producers to leverage their existing plant assets and resources to both make money and create sustainable products. At GlycosBio, we have developed new complementary biological pathways that allow producers to take advantage of their 1st generation infrastructure to not only increase product diversity but also create new avenues of revenue stability while bringing an equilibrium to the supply and demand debate.”
Through the implementation of metabolic engineering, GlycosBio has developed a number of microorganisms that can convert low value by-product feedstock sources such as crude glycerin, gums, and free fatty acids into higher-value green chemicals. GlycosBio’s technology platform provides an alternative to companies interested in biochemical and biofuel production from sugars-based fermentation techniques. By not following the typical sugars-based fermentation research, GlycosBio has created a proprietary technology that provides the industry with additional revenue and profitability opportunities from existing production assets.
To read a summary of the Accenture report, please visit http://www.accenture.com/Global/Services/By_Industry/Energy/R_and_I/Betting-on-Science.htm.
About Glycos Biotechnologies, Inc.
Glycos Biotechnologies, Inc. (GlycosBio) is an emerging biochemical company pioneering the metabolic engineering of microbial strains to consume multiple non sugar-based, low value feedstocks for the production of sustainable chemical intermediates and advanced ethanol. By designing differentiated microorganisms, GlycosBio’s bioconversion technology lowers production cost and provides a non food energy balance savings to the chemical and biofuel industries. GlycosBio is privately held with established global relationships focused on product commercialization. For more information, visit www.glycosbio.com.